SPONSOR
Gruppo Italiano Malattie EMatologiche dell'Adulto
Total Trials
5
Recruiting
5
Phases
Phase 3
Conditions studied: Acute Myeloid LeukemiaHigh-risk MDSMultiple MyelomaMyelodysplastic SyndromesVEXAS
NCT04168502 Phase 3
Recruiting
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Acute Myeloid Leukemia
NCT04184505 Phase 3
Recruiting
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
High-risk MDS
NCT06933277
Recruiting
Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients
Multiple Myeloma
NCT04587856
Recruiting
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
Myelodysplastic Syndromes
NCT06657846
Recruiting
HRQoL and Financial Toxicity in Patients With VEXAS Syndrome
VEXAS